False-Positive Galactomannan Test Results in Multiple Myeloma

Although subclinical IA may be included in a higher GM index, the results may be prone to false positives; particularly in IgG-type MM, the results should thus be interpreted cautiously.

Authors

Institutions

Publication Details

Journal
Diseases
Published
2025-04-17
DOI
https://doi.org/10.3390/diseases13040118
Citations
1
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

False-Positive Galactomannan Test Results in Multiple Myeloma

Shiro Fujii, Kimiko Sogabe, Hirokazu Miki, Shingen Nakamura et al.
1 citations
Diseases
Antifungal resistance and susceptibility
1.40
article

False-Positive Galactomannan Test Results in Multiple Myeloma

Shiro Fujii, Kimiko Sogabe, Hirokazu Miki, Shingen Nakamura, Takeshi Harada, Ryohei Sumitani, Hikaru Yagi, Yusaku Maeda, Masahiro Oura, Ken-ichi Matsuoka
article en
1 citations

Abstract

Although subclinical IA may be included in a higher GM index, the results may be prone to false positives; particularly in IgG-type MM, the results should thus be interpreted cautiously.

DiseasesVol. 13(4)
Tokushima University Hospital (JP), Tokushima University (JP)
Good health and well-being
Openalex Percentile: Top 22%
Antifungal resistance and susceptibility
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.